NeuroBo Pharmaceuticals (NRBO) Short Interest Ratio & Short Volume $2.40 0.00 (0.00%) (As of 10:46 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NeuroBo Pharmaceuticals Short Interest DataNeuroBo Pharmaceuticals (NRBO) has a short interest of 19,200 shares, representing 0.64% of the float (the number of shares available for trading by the public). This marks a -20.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 404,460 shares to cover all short positions.Current Short Interest19,200 sharesPrevious Short Interest24,100 sharesChange Vs. Previous Month-20.33%Dollar Volume Sold Short$49,344.00Short Interest Ratio0.5 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares8,620,000 sharesFloat Size3,000,000 sharesShort Percent of Float0.64%Today's Trading Volume4,266 sharesAverage Trading Volume404,460 sharesToday's Volume Vs. Average1% Short Selling NeuroBo Pharmaceuticals? Sign up to receive the latest short interest report for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNRBO Short Interest Over TimeNRBO Days to Cover Over TimeNRBO Percentage of Float Shorted Over Time Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. NeuroBo Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202419,200 shares $49,344.00 -20.3%0.6%0.5 $2.57 10/15/202424,100 shares $60,973.00 -25.6%0.8%0.6 $2.53 9/30/202432,400 shares $102,708.00 -2.7%1.1%0.8 $3.17 9/15/202433,300 shares $120,213.00 +18.5%1.1%0.6 $3.61 8/31/202428,100 shares $103,689.00 -35.6%1.0%0.5 $3.69 8/15/202443,600 shares $170,476.00 +32.9%1.6%0.9 $3.91 Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202432,800 shares $133,496.00 -37.8%10.1%0.5 $4.07 7/15/202452,700 shares $263,500.00 -43.1%16.2%0.9 $5.00 6/30/202492,600 shares $448,184.00 +58.3%41.3%1.6 $4.84 6/15/202458,500 shares $222,885.00 -6.9%2.9%1.3 $3.81 5/31/202462,800 shares $239,268.00 +74.9%3.1%1.4 $3.81 5/15/202435,900 shares $152,216.00 -11.6%1.8%0.3 $4.24 4/30/202440,600 shares $133,980.00 -21.8%2.1%0.3 $3.30 4/15/202451,900 shares $183,207.00 -16.2%2.6%0 $3.53 3/31/202461,900 shares $253,171.00 -9.5%1.9%0 $4.09 3/15/202468,400 shares $314,640.00 +67.2%2.2%0.1 $4.60 2/29/202440,900 shares $236,811.00 -68.9%1.3%0 $5.79 2/15/2024131,700 shares $636,111.00 +395.1%4.1%0.1 $4.83 1/31/202426,600 shares $86,982.00 +39.3%0.8%0 $3.27 1/15/202419,100 shares $64,558.00 +180.9%0.4%0.6 $3.38 12/31/20236,800 shares $25,136.88 +15.3%0.2%0.2 $3.70 12/15/20235,900 shares $23,590.56 -90.1%0.2%0.5 $4.00 11/30/202359,600 shares $26,700.80 -31.8%N/A1 $0.45 11/15/202387,400 shares $37,599.48 -2.7%N/A1.3 $0.43 10/31/202389,800 shares $37,805.80 -29.5%N/A0.8 $0.42 10/15/2023127,400 shares $60,757.06 +4.3%N/A0.8 $0.48 9/30/2023122,200 shares $58,167.20 +11.1%N/A0.5 $0.48 9/15/2023110,000 shares $59,367.00 -20.1%N/A0.3 $0.54 8/31/2023137,700 shares $61,290.27 -48.0%0.8%0.4 $0.45 8/15/2023265,000 shares $163,770.00 +217.4%1.5%0.7 $0.62 7/31/202383,500 shares $42,835.50 -57.9%0.7%0.2 $0.51 7/15/2023198,500 shares $86,645.25 -67.5%1.5%0.5 $0.44 6/30/2023611,400 shares $267,242.94 +224.5%4.6%1.3 $0.44 6/15/2023188,400 shares $93,069.60 -20.6%1.4%0.5 $0.49 5/31/2023237,400 shares $132,944.00 -9.0%1.8%0.6 $0.56 5/15/2023261,000 shares $154,746.90 +15.6%2.0%0.5 $0.59 4/30/2023225,800 shares $144,512.00 +33.9%1.7%0.4 $0.64 4/15/2023168,600 shares $123,078.00 -26.5%2.3%0.2 $0.73 3/31/2023229,300 shares $162,871.79 -13.3%3.1%0.3 $0.71 3/15/2023264,500 shares $177,320.80 +28.1%4.2%0.2 $0.67Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. 2/28/2023206,500 shares $132,160.00 -40.9%3.3%0.1 $0.64 2/15/2023349,400 shares $251,218.60 -46.1%5.6%0.1 $0.72 1/31/2023648,700 shares $512,473.00 +359.7%10.3%0.2 $0.79 1/15/2023141,100 shares $108,618.78 -85.3%2.2%0 $0.77 12/30/2022958,400 shares $687,652.00 -14.4%15.3%0.3 $0.72 12/15/20221,120,000 shares $1.69 million +29.4%N/A0.3 $1.51 11/30/2022865,400 shares $1.25 million -47.6%N/A0.3 $1.45 11/15/20221,650,000 shares $2.34 million +837.0%45.1%0.6 $1.42 10/31/2022176,100 shares $1.35 million +257.2%9.2%0.1 $7.68 10/15/202249,300 shares $628,575.00 -46.8%9.6%0.1 $12.75 9/30/202292,600 shares $1.27 million -12.3%17.9%0.2 $13.69 9/15/2022105,600 shares $2.62 million -34.5%24.7%0.2 $24.82 8/31/2022161,300 shares $51,422.44 -7.5%1.3%0.1 $0.32 8/15/2022174,400 shares $71,172.64 -5.4%1.4%2 $0.41 7/31/2022184,300 shares $77,664.02 -17.7%1.4%1.9 $0.42 7/15/2022223,900 shares $125,406.39 +2.8%1.9%1.9 $0.56 6/30/2022217,900 shares $104,548.42 +17.2%1.9%1.7 $0.48 6/15/2022186,000 shares $74,772.00 -7.4%1.6%1.4 $0.40 5/31/2022200,900 shares $89,199.60 -15.8%1.7%1 $0.44 5/15/2022238,500 shares $121,444.20 -13.1%2.1%1.3 $0.51 4/30/2022274,400 shares $176,439.20 -8.8%2.4%1.5 $0.64 4/15/2022301,000 shares $261,659.30 -7.9%2.6%1.6 $0.87 3/31/2022326,900 shares $294,896.49 +31.6%2.9%1.6 $0.90 3/15/2022248,500 shares $191,842.00 +9.2%2.2%0.4 $0.77 2/28/2022227,500 shares $179,725.00 -6.0%2.0%0.4 $0.79 2/15/2022242,100 shares $225,153.00 -35.7%2.1%0.4 $0.93 1/31/2022376,500 shares $391,560.00 -9.5%3.3%0.6 $1.04 1/15/2022416,000 shares $544,960.00 +423.9%3.6%0.6 $1.31 12/31/202179,400 shares $96,868.00 +44.9%0.7%0.1 $1.22 12/15/202154,800 shares $76,720.00 -34.7%0.5%0.1 $1.40 11/30/202183,900 shares $135,079.00 +75.5%0.7%0.2 $1.61 11/15/202147,800 shares $87,474.00 -53.9%0.4%0.1 $1.83 10/29/2021103,600 shares $183,372.00 -77.5%1.1%0.2 $1.77 10/15/2021460,600 shares $875,140.00 +340.8%4.9%0.8 $1.90 9/30/2021104,500 shares $388,740.00 -11.1%1.1%0 $3.72 9/15/2021117,600 shares $453,936.00 -18.8%1.5%0.1 $3.86 8/31/2021144,800 shares $599,472.00 -40.8%1.8%0.1 $4.14 8/13/2021244,500 shares $865,530.00 -43.0%3.1%0.1 $3.54 7/30/2021429,200 shares $1.41 million +122.4%5.4%0.2 $3.29 7/15/2021193,000 shares $528,820.00 -14.8%2.5%0.1 $2.74 6/30/2021226,400 shares $753,912.00 -52.8%2.9%0.9 $3.33 6/15/2021479,300 shares $1.60 million +18.8%6.2%1.9 $3.34 5/28/2021403,400 shares $1.14 million +7.1%5.3%3.3 $2.82 5/14/2021376,600 shares $1.04 million +4.8%4.9%2.6 $2.77 4/30/2021359,300 shares $1.28 million +4.3%4.7%1.7 $3.56 4/15/2021344,500 shares $1.30 million +8.4%4.5%0.9 $3.76 3/31/2021317,800 shares $1.35 million +143.3%4.2%0.8 $4.26 3/15/2021130,600 shares $578,558.00 -6.6%1.7%0.3 $4.43 2/26/2021139,800 shares $648,672.00 -42.1%1.6%0.4 $4.64 2/12/2021241,500 shares $1.34 million -73.3%2.7%0.7 $5.53Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. 1/29/2021902,900 shares $5.16 million +545.4%14.3%2.9 $5.72 1/15/2021139,900 shares $864,582.00 +2.6%2.2%1.3 $6.18 12/31/2020136,400 shares $754,292.00 +11.7%2.9%2.2 $5.53 12/15/2020122,100 shares $667,887.00 -3.3%2.2%6.9 $5.47 11/30/2020126,300 shares $684,546.00 -0.8%2.3%8 $5.42 11/15/2020127,300 shares $669,598.00 +1.9%2.3%7.4 $5.26 10/30/2020124,900 shares $666,966.00 -5.5%2.2%6.8 $5.34 10/15/2020132,200 shares $831,538.00 -1.9%2.4%4.6 $6.29 9/30/2020134,800 shares $757,576.00 +7.8%2.4%3.2 $5.62 9/15/2020125,100 shares $783,126.00 -17.0%2.2%1.9 $6.26 8/31/2020150,700 shares $916,256.00 -11.4%2.7%2.1 $6.08 8/14/2020170,100 shares $1.12 million -16.0%3.1%2.3 $6.57 7/31/2020202,500 shares $1.30 million -34.7%3.7%2.9 $6.41 7/15/2020309,900 shares $2.38 million +54.3%5.6%5 $7.69 6/30/2020200,800 shares $1.67 million +184.0%3.6%3.6 $8.31 6/15/202070,700 shares $671,650.00 +12.0%1.3%2.3 $9.50 5/29/202063,100 shares $831,027.00 +3.6%1.1%2.7 $13.17 5/15/202060,900 shares $801,444.00 +407.5%1.1%2.7 $13.16 4/30/202012,000 shares $170,520.00 +100.0%0.2%0.4 $14.21 4/15/20206,000 shares $100,200.00 -18.9%0.1%0.2 $16.70 3/31/20207,400 shares $110,482.00 -28.2%0.1%0.3 $14.93 3/13/202010,300 shares $297,258.00 -64.0%0.2%0.6 $28.86 2/28/202028,600 shares $256,542.00 -8.6%0.5%1.1 $8.97 2/14/202031,300 shares $453,850.00 +69.2%0.5%1.3 $14.50 1/31/202018,500 shares $315,055.00 +110.2%0.2%1.6 $17.03 1/15/20208,800 shares $129,360.00 -17.8%0.1%1.3 $14.70 12/31/201910,700 shares $87,847.00 No Change0.3%1.9 $8.21 NRBO Short Interest - Frequently Asked Questions What is NeuroBo Pharmaceuticals' current short interest? Short interest is the volume of NeuroBo Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 19,200 shares of NRBO short. 0.64% of NeuroBo Pharmaceuticals' shares are currently sold short. Learn More on NeuroBo Pharmaceuticals' current short interest. What is a good short interest percentage for NeuroBo Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.64% of NeuroBo Pharmaceuticals' floating shares are currently sold short. Is NeuroBo Pharmaceuticals' short interest increasing or decreasing? NeuroBo Pharmaceuticals saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 19,200 shares, a drop of 20.3% from the previous total of 24,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NeuroBo Pharmaceuticals' float size? NeuroBo Pharmaceuticals currently has issued a total of 8,620,000 shares. Some of NeuroBo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroBo Pharmaceuticals currently has a public float of 3,000,000 shares. How does NeuroBo Pharmaceuticals' short interest compare to its competitors? 0.64% of NeuroBo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to NeuroBo Pharmaceuticals: CASI Pharmaceuticals, Inc. (1.90%), Chimerix, Inc. (1.90%), Allakos Inc. (1.91%), 23andMe Holding Co. (7.86%), ESSA Pharma Inc. (2.59%), Clearside Biomedical, Inc. (2.32%), I-Mab (0.73%), PDS Biotechnology Co. (11.95%), Oncolytics Biotech Inc. (3.65%), FibroBiologics, Inc. (8.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short NeuroBo Pharmaceuticals stock? Short selling NRBO is an investing strategy that aims to generate trading profit from NeuroBo Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NeuroBo Pharmaceuticals? A short squeeze for NeuroBo Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NRBO, which in turn drives the price of the stock up even further. How often is NeuroBo Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRBO, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies CASI Short Interest Data CMRX Short Interest Data ALLK Short Interest Data ME Short Interest Data EPIX Short Interest Data CLSD Short Interest Data IMAB Short Interest Data PDSB Short Interest Data ONCY Short Interest Data FBLG Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NRBO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRBO Stock Alerts